Analyzing Currenc Group (NASDAQ:CURR) & OSR (NASDAQ:OSRH)

OSR (NASDAQ:OSRHGet Free Report) and Currenc Group (NASDAQ:CURRGet Free Report) are both small-cap manufacturing companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations.

Profitability

This table compares OSR and Currenc Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OSR N/A -6.66% -4.90%
Currenc Group -84.72% N/A -34.02%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for OSR and Currenc Group, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OSR 1 0 0 0 1.00
Currenc Group 1 1 0 1 2.33

Currenc Group has a consensus price target of $3.50, suggesting a potential upside of 77.66%. Given Currenc Group’s stronger consensus rating and higher probable upside, analysts clearly believe Currenc Group is more favorable than OSR.

Insider & Institutional Ownership

55.3% of OSR shares are owned by institutional investors. Comparatively, 56.0% of Currenc Group shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Comparatively, 17.8% of Currenc Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

OSR has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, Currenc Group has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500.

Earnings & Valuation

This table compares OSR and Currenc Group”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OSR N/A N/A -$2.41 million ($1.12) -0.44
Currenc Group $46.44 million 3.23 -$39.47 million ($0.88) -2.24

OSR has higher earnings, but lower revenue than Currenc Group. Currenc Group is trading at a lower price-to-earnings ratio than OSR, indicating that it is currently the more affordable of the two stocks.

Summary

Currenc Group beats OSR on 7 of the 13 factors compared between the two stocks.

About OSR

(Get Free Report)

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

About Currenc Group

(Get Free Report)

Currenc Group, Inc. engages in operating a fintech banking platform. It operates through the following segments: Remittance Services, Sales of Airtime, and Other Services. The company is headquartered in Singapore.

Receive News & Ratings for OSR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OSR and related companies with MarketBeat.com's FREE daily email newsletter.